Evidence map›Paper›PMID 33122996›Full record

ReviewFrontiers in neuroscience2020

What's That (Blue) Spot on my MRI? Multimodal Neuroimaging of the Locus Coeruleus in Neurodegenerative Disease.

Michael Kelberman, Shella Keilholz, David Weinshenker

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 48 citations in OpenAlex.

  1. Sex differences in neuromodulatory subcortical systems and their implications for Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  2. Positron Emission Tomography (PET) Neuroimaging of theThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer's disease.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  18. Review
  19. Review
  20. Locus Coeruleus Shows a Spatial Pattern of Structural Disintegration in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Michael KelbermanDepartment of Human Genetics, Emory University, Atlanta, GA, United States.
Shella KeilholzThe Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Emory University, Atlanta, GA, United States.
David WeinshenkerDepartment of Human Genetics, Emory University, Atlanta, GA, United States.
Emory University · USGeorgia Institute of Technology · US

Funding

Training In Systems And Integrative Biology NeuroscienceT32NS096050 · NINDS · EMORY UNIVERSITY · PI Yoland Smith · 2016 to 2026
$3.9M
Contribution of Ultra Low Frequency LFPs to Functional MRIR01NS078095 · NINDS · EMORY UNIVERSITY · PI KEILHOLZ, SHELLA D · 2012 to 2022
$3.4M
Mechanisms underlying selective vulnerability of locus coeruleus neurons in Alzheimer's diseaseRF1AG061175 · NIA · EMORY UNIVERSITY · PI KANG, SEONG SU, WEINSHENKER, DAVID · 2019 to 2019
$2.8M
Impact of locus coeruleus-derived tau pathology in a rodent model of early Alzheimer's diseaseR01AG062581 · NIA · EMORY UNIVERSITY · PI KEILHOLZ, SHELLA D, WEINSHENKER, DAVID · 2020 to 2024
$2.3M
Local and global consequences of hyperphosphorylated tau in the locus coeruleus in Alzheimer's DiseaseF31AG069502 · NIA · EMORY UNIVERSITY · PI KELBERMAN, MICHAEL · 2020 to 2022
$138k
NIA NIH HHS F31 AG069502NIA NIH HHS R01 AG062581NIA NIH HHS RF1 AG061175NINDS NIH HHS R01 NS078095NINDS NIH HHS T32 NS096050
6 · The paper itself

Abstract

The locus coeruleus (LC) has long been underappreciated for its role in the pathophysiology of Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative disorders. While AD and PD are distinct in clinical presentation, both are characterized by prodromal protein aggregation in the LC, late-stage degeneration of the LC, and comorbid conditions indicative of LC dysfunction. Many of these early studies were limited to post-mortem histological techniques due to the LC's small size and location deep in the brainstem. Thus, there is a growing interest in utilizing

Indexed as

Alzheimer’s diseaseanimal modelslocus coeruleusmagnetic resonance imagingneurodegenerationParkinson’s diseasepositron emission tomography

Identifiers

PMID33122996
PMCPMC7573566
OpenAlexW3092162390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.